Mapping PD-1 immunoreceptor signalling pathways

被引：0
|
作者：
Kreileder, M. [1 ]
Nabhan, M. [1 ]
Egan, D. [1 ]
Zhernovkov, V. [1 ]
Glennon, K. [2 ]
Barrett, I. [3 ]
Bendtsen, C. [3 ]
Dovedi, S. [3 ]
Valge-Archer, V. [3 ]
Wilkinson, R. [3 ]
Brennan, D. [1 ,2 ]
Kolch, W. [1 ]
机构：
[1] Univ Coll Dublin, Syst Biol Ireland, Precis Oncol Ireland, Belfield, Ireland
[2] Mater Misericoridae Univ Hosp, Catherine McAuley Res Ctr, Dublin, Ireland
[3] AstraZeneca, Cambridge Biomed Campus, Cambridge, England
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P 85
引用
收藏
页码：125 / 125
页数：1
相关论文
共 50 条
  • [31] PD-1/PD-L1, MDSC Pathways, and Checkpoint Inhibitor Therapy in Ph(-) Myeloproliferative Neoplasm: A Review
    Wang, Jen-Chin
    Sun, Lishi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [32] Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
    Wang, Rong
    He, Shiwei
    Long, Jun
    Wang, Yian
    Jiang, Xianjie
    Chen, Mingfen
    Wang, Jie
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [33] Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
    Nishimura, H
    Nose, M
    Hiai, H
    Minato, N
    Honjo, T
    IMMUNITY, 1999, 11 (02) : 141 - 151
  • [34] PD-1/PD-L1 inhibitors
    Sunshine, Joel
    Taube, Janis M.
    CURRENT OPINION IN PHARMACOLOGY, 2015, 23 : 32 - 38
  • [35] PD-1/PD-L1 in disease
    Kuol, Nyanbol
    Stojanovska, Lily
    Nurgali, Kulmira
    Apostolopoulos, Vasso
    IMMUNOTHERAPY, 2018, 10 (02) : 149 - 161
  • [36] Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
    Gaixia He
    Henghui Zhang
    Jinxue Zhou
    Beibei Wang
    Yanhui Chen
    Yaxian Kong
    Xingwang Xie
    Xueyan Wang
    Ran Fei
    Lai Wei
    Hongsong Chen
    Hui Zeng
    Journal of Experimental & Clinical Cancer Research, 34
  • [37] PD-1/PD-L1 signalling axis, "a double-edged sword" in DSS induced colitis mouse model
    Yang, Tao
    Lu, Rongfei
    Lian, Kaixia
    Zhang, Likun
    Wang, Dawei
    Feng, Xinhe
    An, Xiaoyu
    Wang, Jessie
    Edwards, Carl K.
    CANCER RESEARCH, 2023, 83 (07)
  • [38] Peritumoural neutrophils negatively regulate adaptive immunity via the PD-L1/PD-1 signalling pathway in hepatocellular carcinoma
    He, Gaixia
    Zhang, Henghui
    Zhou, Jinxue
    Wang, Beibei
    Chen, Yanhui
    Kong, Yaxian
    Xie, Xingwang
    Wang, Xueyan
    Fei, Ran
    Wei, Lai
    Chen, Hongsong
    Zeng, Hui
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
  • [39] PD-1 expression by canine T cells and functional effects of PD-1 blockade
    Coy, J.
    Caldwell, A.
    Chow, L.
    Guth, A.
    Dow, S.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (04) : 1487 - 1502
  • [40] IS THERE A ROLE FOR INCREASED PD-1 AND PD-1 LIGAND EXPRESSIONS AFTER SEPTIC SHOCK?
    Guignant, Caroline
    Venet, Fabienne
    Lepape, Alain
    Monneret, Guillaume
    SHOCK, 2009, 32 : 20 - 20
12345